Analytical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis.
Ferhan QureshiWayne HuLouisa LohHemali PatelMaria DeGuzmanMichael BecichFatima Rubio da CostaVictor GehmanFujun ZhangJohn FoleyTanuja ChitnisPublished in: Proteomics. Clinical applications (2023)
Analytical validation of this multi-protein, serum-based assay is the first step in establishing its potential utility as a quantitative, minimally invasive, and scalable biomarker panel to enhance the standard of care for patients with MS.
Keyphrases
- disease activity
- multiple sclerosis
- minimally invasive
- rheumatoid arthritis
- systemic lupus erythematosus
- rheumatoid arthritis patients
- high throughput
- ankylosing spondylitis
- protein protein
- healthcare
- mass spectrometry
- palliative care
- liquid chromatography
- juvenile idiopathic arthritis
- amino acid
- binding protein
- high resolution
- pain management